Nkgen BiotechNKGN
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.06avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Nkgen Biotech Inc. (NKGN) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Meteora Capital, LLC ($165K).
- Company
- Nkgen Biotech Inc.
- CUSIP
- 65488A101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Meteora Capital, LLC | 0.01% | No change | 2,755,935 | $165K |
"% of holder's portfolio" is NKGN's weight in each manager's 13F, not the share of Nkgen Biotech Inc. the manager owns.